The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA)

被引：10

作者：

Speden, D

Nicklason, F

Francis, H

Ward, J

机构：

[1] ROYAL HOBART HOSP,DEPT RADIAT ONCOL,HOBART,TAS 7001,AUSTRALIA

[2] ROYAL HOBART HOSP,DEPT ONCOL,HOBART,TAS 7001,AUSTRALIA

来源：

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE | 1997年 / 27卷 / 03期

关键词：

hypertrophic osteoarthropathy; bronchogenic carcinoma; pamidronate;

D O I：

10.1111/j.1445-5994.1997.tb01983.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Hypertrophic pulmonary osteoarthropathy (HPOA) secondary to bronchogenic carcinoma can be associated with severe, disabling pain which is not always responsive to conventional treatment. Aim: To report on the use of pamidronate to control resistant pain in HPOA in three cases. Methods: A retrospective review of reported pain, chest X-ray and radionuclide bone scans was made. Results: Pain relief was achieved in all three cases together with reduced radiolabel uptake in two cases. Conclusions: Pamidronate appears to be an effective therapy for HPOA. Further investigation is warranted.

引用

页码：307 / 310

页数：4

共 8 条

[1] TREATMENT OF RESISTANT PAIN IN HYPERTROPHIC PULMONARY ARTHROPATHY WITH KETOROLAC [J].

BLACKWELL, N ;

BANGHAM, L ;

HUGHES, M ;

MELZACK, D ;

TROTMAN, I .

THORAX, 1993, 48 (04) :401-401

[2]

FITTON A, 1992, DRUGS, V41, P290

[3]

MATUCCICERINIC M, 1992, CLIN EXP RHEUMATOL, V10, P67

[4]

Nishi K, 1994, Nihon Kyobu Shikkan Gakkai Zasshi, V32, P271

[5]

PINEDA C, 1992, CLIN EXP RHEUMATOL, V10, P27

[6]

ROY DA, 1989, TXB RHEUMATOLOGY, P1666

[7]

SCHUMACHER HR, 1992, CLIN EXP RHEUMATOL, V10, P35

[8]

Suteanu S., 1992, Revue Roumaine de Medecine Interne, V30, P281

← 1 →